These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 32723793)

  • 21. Probiotic Escherichia coli Nissle 1917 inhibits bacterial persisters that survive fluoroquinolone treatment.
    Hare PJ; Englander HE; Mok WWK
    J Appl Microbiol; 2022 Jun; 132(6):4020-4032. PubMed ID: 35332984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species.
    Van Acker H; Sass A; Bazzini S; De Roy K; Udine C; Messiaen T; Riccardi G; Boon N; Nelis HJ; Mahenthiralingam E; Coenye T
    PLoS One; 2013; 8(3):e58943. PubMed ID: 23516582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Genes Involved in Bacteriostatic Antibiotic-Induced Persister Formation.
    Cui P; Niu H; Shi W; Zhang S; Zhang W; Zhang Y
    Front Microbiol; 2018; 9():413. PubMed ID: 29559967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reassessing the Role of Type II Toxin-Antitoxin Systems in Formation of Escherichia coli Type II Persister Cells.
    Goormaghtigh F; Fraikin N; Putrinš M; Hallaert T; Hauryliuk V; Garcia-Pino A; Sjödin A; Kasvandik S; Udekwu K; Tenson T; Kaldalu N; Van Melderen L
    mBio; 2018 Jun; 9(3):. PubMed ID: 29895634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidrug tolerance of biofilms and persister cells.
    Lewis K
    Curr Top Microbiol Immunol; 2008; 322():107-31. PubMed ID: 18453274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stationary-Phase Persisters to Ofloxacin Sustain DNA Damage and Require Repair Systems Only during Recovery.
    Völzing KG; Brynildsen MP
    mBio; 2015 Sep; 6(5):e00731-15. PubMed ID: 26330511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Energy production genes sucB and ubiF are involved in persister survival and tolerance to multiple antibiotics and stresses in Escherichia coli.
    Ma C; Sim S; Shi W; Du L; Xing D; Zhang Y
    FEMS Microbiol Lett; 2010 Feb; 303(1):33-40. PubMed ID: 20041955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens.
    Goneau LW; Yeoh NS; MacDonald KW; Cadieux PA; Burton JP; Razvi H; Reid G
    Antimicrob Agents Chemother; 2014; 58(4):2089-97. PubMed ID: 24449771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring Persister Resuscitation with Flow Cytometry.
    Mohiuddin SG; Orman MA
    Methods Mol Biol; 2021; 2357():209-222. PubMed ID: 34590261
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Kim H; Oh S; Song S
    J Microbiol Biotechnol; 2024 Apr; 34(4):854-862. PubMed ID: 38326923
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibiotic induced bacterial lysis provides a reservoir of persisters.
    Podlesek Z; Butala M; Šakanović A; Žgur-Bertok D
    Antonie Van Leeuwenhoek; 2016 Apr; 109(4):523-8. PubMed ID: 26821377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (p)ppGpp-Dependent Persisters Increase the Fitness of Escherichia coli Bacteria Deficient in Isoaspartyl Protein Repair.
    VandenBerg KE; Ahn S; Visick JE
    Appl Environ Microbiol; 2016 Sep; 82(17):5444-54. PubMed ID: 27371580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The frequency of persisters in Escherichia coli reflects the kinetics of awakening from dormancy.
    Jõers A; Kaldalu N; Tenson T
    J Bacteriol; 2010 Jul; 192(13):3379-84. PubMed ID: 20435730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudomonas syringae pv.
    Patel RR; Kandel PP; Traverso E; Hockett KL; Triplett LR
    mBio; 2021 Apr; 12(2):. PubMed ID: 33849974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type I toxin-dependent generation of superoxide affects the persister life cycle of Escherichia coli.
    Edelmann D; Berghoff BA
    Sci Rep; 2019 Oct; 9(1):14256. PubMed ID: 31582786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extreme Antibiotic Persistence via Heterogeneity-Generating Mutations Targeting Translation.
    Khare A; Tavazoie S
    mSystems; 2020 Jan; 5(1):. PubMed ID: 31964772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Novel Genes Involved in
    Li T; Wang J; Cao Q; Li F; Han J; Zhu B; Zhang Y; Niu H
    Front Cell Infect Microbiol; 2020; 10():581986. PubMed ID: 33117736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of protein synthesis eradicates persister cells of
    Paranjape SS; Shashidhar R
    3 Biotech; 2019 Nov; 9(11):380. PubMed ID: 31588404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced antibiotic resistance development from fluoroquinolone persisters after a single exposure to antibiotic.
    Barrett TC; Mok WWK; Murawski AM; Brynildsen MP
    Nat Commun; 2019 Mar; 10(1):1177. PubMed ID: 30862812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Genetic Determinant of Persister Cell Formation in Bacterial Pathogens.
    Cameron DR; Shan Y; Zalis EA; Isabella V; Lewis K
    J Bacteriol; 2018 Sep; 200(17):. PubMed ID: 29941425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.